Jason S. Kerr sold $386k of RXO
Chief Accounting Officer at RXO, Inc.. 33,343 shares at an average of $11.57, traded Nov 10, 2025, filed Nov 12, 2025.
Score components
- +15RoleOfficer
- +16Trade size$386k at market
- +10Share of holdings soldSold 43% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950142-25-002949, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 10, 2025 | SOpen-market sale Common Stock | -33,343 | $11.57 | $386k | 43,558 | Nov 12, 2025 |
Related signals
Other insiders at RXO, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | RXObuy RXO, Inc. | MFN Partners, LP owner | $6.4M 532,276 shares | +2% | |
| 57Moderate | RXO, Inc. | Troy A. Cooper director | $88k 8,317 shares | +3% | |
| 61Notable | RXO, Inc. | Adrian Kingshott director | $101k 9,350 shares | +11% | |
| 61Notable | RXO, Inc. | Adrian Kingshott director | $101k 9,350 shares | +11% | |
| 71Notable | RXO, Inc. | Thomas A Szlosek director | $251k 20,308 shares | +125% | |
| 77Notable | RXO, Inc. | Andrew M. Wilkerson Chief Executive Officer | $149k 11,625 shares | - | |
| 48Moderate | RXObuy RXO, Inc. | Thomas A Szlosek director | $125k 7,500 shares | +86% | |
| 42Moderate | RXObuy RXO, Inc. | Thomas A Szlosek director | $125k 8,700 shares | - | |
| 25Weak | RXObuy RXO, Inc. | Michelle Nettles director | $50k 1,800 shares | +13% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.